FutuRx
Anna Pasechnek has worked in the scientific field for the past two years. Anna began their career in 2020 as the Scientific Director and Clinical Manager at MYOR. In 2022, they moved to FutuRx, where they currently serve as a Scientist at A2i Therapeutics ltd.
Anna Pasechnek received their Doctor of Philosophy - PhD from Tel Aviv University in 2019, with a field of study in Interactions between pathogenic bacteria and its viruses. Anna also received their Master of Science (M.Sc.) from Tel Aviv University in 2008, with a field of study in Microbiology, General.
This person is not in the org chart
This person is not in any offices
FutuRx
FutuRx is a biotech incubator founded by three leading global healthcare players. FutuRx leverages its access to the Israeli biotech industry, and to leading research institutes in Israel and worldwide, to identify and develop highly innovative technologies. Experts at Takeda, J&J, and OrbiMed are deeply involved in the project selection process and during the incubator period of each company. The result is a clear impact on the efficient translation of innovative research to clinically meaningful products.